1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns
Sign Up to like & getrecommendations! Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa439.1501
Abstract: Antimicrobial dosing in moderate/severe burns patients is complicated due to the potential unpredictable hyperdynamic pathophysiologic states including 1) hypoproteinemia, 2) acute kidney injury and 3) onset of septicemia. Therefore, distribution assumptions about the population pharmacokinetic… read more here.
Keywords: tazobactam; thickness burns; 1319 pharmacokinetics; compartment ... See more keywords